Cellect Biotechnology Ltd. Warrants to Purchase ADRs
APOPW
APOPW was delisted on the 3rd of August, 2021.
1 hedge funds and large institutions have $1K invested in Cellect Biotechnology Ltd. Warrants to Purchase ADRs in 2020 Q1 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 1 reducing their positions, and 0 closing their positions.
0% more funds holding
Funds holding: 1 → 1 (0)
0% more capital invested
Capital invested by funds: $1K → $1K ($0)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$157 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $1K | -$157 | -2,080 | -11% |
|
APOPW Hedge Fund Activity: Q1 2020 in Review
1 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Cellect Biotechnology Ltd. Warrants to Purchase ADRs (APOPW) for Q1 2020, worth a combined $1K — unchanged from a quarter earlier.
Fund positioning in APOPW was balanced in Q1 2020: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.
The largest seller was Susquehanna International Group, cutting an estimated $157.
- 1 institutional investor held Cellect Biotechnology Ltd. Warrants to Purchase ADRs (APOPW) as of Q1 2020, unchanged from Q4 2019.
- Funds reported $1K of Cellect Biotechnology Ltd. Warrants to Purchase ADRs stock for Q1 2020, unchanged quarter-over-quarter.
- 0 funds opened new Cellect Biotechnology Ltd. Warrants to Purchase ADRs positions in Q1 2020 and 0 closed out.
- The largest Cellect Biotechnology Ltd. Warrants to Purchase ADRs seller in Q1 2020 was Susquehanna International Group, an estimated $157 sold.
Based on aggregated 13F filings for Q1 2020.